Nimgenetics is one of the largest Spanish genetic labs and is selling across the Latino world. Here Enrique gives his personal view of the future of genetics. What price will tests need to hit before becoming mass B2B and B2C markets? What are the implications of 4P Medicine? And how can the sector deal with the huge challenges it faces around IP, educating the medical profession and staff shortages? Where will for-profit labs play in this?